Biotinylated Human PADI4 Protein (Primary Amine Labeling) (PAD-HE104B)
|Recombinant Biotinylated Human PADI4 Protein(Primary Amine Labeling) is expressed from E.coli with His tag at the N-Terminus.It contains Met1-Pro663.
|Peptidylarginine deiminase type4 (PADI4) was firstly identified as a non-MHC RA genetic risk factor. Furthermore, PADI4 risk allele possessed the association with bone damage regardless of anti citrullinated peptide antibody (ACPA) positivity in Asian RA patients. PADI4 gene codes PAD4 protein which has post-translational modification activity (citrullination). Padi4 is mainly expressed in myeloid cells and granulocytes.
|The protein has a predicted MW of 76.6 kDa same as Tris-Bis PAGE result.
|> 95% as determined by Tris-Bis PAGE
|Less than 1EU per ug by the LAL method.
|Shipped with dry ice.
|Supplied as 0.22um filtered solution in LTSB.
|Stability And Storage
|Valid for 12 months from date of receipt when stored at -80°C.；Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.